How Acceptable are Antiretrovirals for the Prevention of Sexually Transmitted HIV?: A Review of Research on the Acceptability of Oral Pre-exposure Prophylaxis and Treatment as Prevention

被引：0
作者：
Ingrid Young
Lisa McDaid
机构：
[1] University of Glasgow,MRC/CSO Social and Public Health Sciences Unit
来源：
AIDS and Behavior | 2014年 / 18卷
关键词：
Pre-exposure prophylaxis; Treatment as prevention; Acceptability; HIV prevention;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Recent research has demonstrated how antiretrovirals (ARVs) could be effective in the prevention of sexually transmitted HIV. We review research on the acceptability of oral pre-exposure prophylaxis (PrEP) and treatment as prevention (TasP) for HIV prevention amongst potential users. We consider with whom, where and in what context this research has been conducted, how acceptability has been approached, and what research gaps remain. Findings from 33 studies show a lack of TasP research, PrEP studies which have focused largely on men who have sex with men (MSM) in a US context, and varied measures of acceptability. In order to identify when, where and for whom PrEP and TasP would be most appropriate and effective, research is needed in five areas: acceptability of TasP to people living with HIV; motivation for PrEP use and adherence; current perceptions and management of risk; the impact of broader social and structural factors; and consistent definition and operationalisation of acceptability which moves beyond adherence.
引用
收藏
页码：195 / 216
页数：21
相关论文
共 200 条
  • [1] Padian NS(2008)Biomedical interventions to prevent HIV infection: evidence, challenges, and way forward Lancet 372 585-599
  • [2] Buve A(2011)Post-exposure prophylaxis for HIV infection Expert Rev Anti Infect Ther 9 431-442
  • [3] Balkus J(2003)Sustaining safe practice: twenty years on Soc Sci Med 57 1-12
  • [4] Serwadda D(2012)Beyond the distinction between biomedical and social dimensions of HIV prevention through the lens of a social public health Am J Public Health 102 789-799
  • [5] Cates W(2012)The beginning of the end of AIDS? N Engl J Med 367 685-687
  • [6] Rey D(2012)Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men Sci Transl Med 4 1-8
  • [7] Kippax S(2011)Interim guidance: Pre-exposure prophylaxis for the prevention of HIV infection in men who have sex with men Morbidity and Mortality Weekly Report 60 65-8
  • [8] Race K(2012)Interim guidance: pre-exposure prophylaxis for the prevention of HIV infection in heterosexually active adults Morbidity and Mortality Weekly Report 61 586-4
  • [9] Kippax S(2012)The British HIV association/British association for sexual health and HIV position statement on pre-exposure prophylaxis in the UK Int J STD AIDS 23 1-105
  • [10] Stephenson N(2012)HIV treatment as prevention and HPTN 052 Curr Opin HIV AIDS 7 99-262
12345678910